| Di-peptide-modified gemini surfactants as gene delivery vectors: exploring the role of the alkyl tail in their physicochemical behavior and biological activity MA Al-Dulaymi, JM Chitanda, W Mohammed-Saeid, HY Araghi, ... The AAPS journal 18, 1168-1181, 2016 | 35 | 2016 |
| Cellular uptake and distribution of gemini surfactant nanoparticles used as gene delivery agents W Jin, M Al-Dulaymi, I Badea, SC Leary, J Rehman, A El-Aneed The AAPS journal 21, 1-11, 2019 | 21 | 2019 |
| Design and evaluation of RGD-modified gemini surfactant-based lipoplexes for targeted gene therapy in melanoma model W Mohammed-Saeid, J Chitanda, M Al-Dulaymi, R Verrall, I Badea Pharmaceutical research 34, 1886-1896, 2017 | 20 | 2017 |
| Molecular engineering as an approach to modulate gene delivery efficiency of peptide-modified gemini surfactants M Al-Dulaymi, D Michel, JM Chitanda, A El-Aneed, RE Verrall, ... Bioconjugate chemistry 29 (10), 3293-3308, 2018 | 12 | 2018 |
| Tandem mass spectrometric analysis of novel peptide‐modified gemini surfactants used as gene delivery vectors M Al‐Dulaymi, A El‐Aneed Journal of Mass Spectrometry 52 (6), 353-366, 2017 | 11 | 2017 |
| A 89Zr-labeled lipoplex nanosystem for image-guided gene delivery: design, evaluation of stability and in vivo behavior I Hajdu, A Makhlouf, VR Solomon, D Michel, M Al-Dulaymi, KM Wasan, ... International journal of nanomedicine, 7801-7818, 2018 | 10 | 2018 |
| The development of simple flow injection analysis tandem mass spectrometric methods for the cutaneous determination of peptide-modified cationic gemini surfactants used as gene … M Al-Dulaymi, D Michel, JM Chitanda, I Badea, A El-Aneed Journal of pharmaceutical and biomedical analysis 159, 536-547, 2018 | 9 | 2018 |
| Peptide-Modified gemini surfactants: preparation and characterization for gene delivery M Al-Dulaymi, W Mohammed-Saeid, A El-Aneed, I Badea Pharmaceutical Nanotechnology: Basic Protocols, 203-225, 2019 | 6 | 2019 |
| Gemini surfactant-based nanoparticles T-box1 gene delivery as a novel approach to promote epithelial stem cells differentiation and dental enamel formation F Mohabatpour, M Al-Dulaymi, L Lobanova, B Scutchings, S Papagerakis, ... Biomaterials Advances 137, 212844, 2022 | 3 | 2022 |
| Cationic Gemini Surfactants as Genes and Drug Carriers M Al-Dulaymi, A El-Aneed, I Badea Drug Delivery Using Nanomaterials, 329-353, 2022 | | 2022 |
| DEVELOPMENT OF PEPTIDE-MODIFIED GEMINI SURFACTANTS AS NON-VIRAL GENE DELIVERY SYSTEM. MAM Al-Dulaymi University of Saskatchewan, 2018 | | 2018 |
| Streamlined identification and quantitation of impurities of the ionizable lipid ALC-0315 for rapid and confident vendor-to-vendor raw material assessment to ensure mRNA-LNP … M Al-Dulaymi, Z Yang, S Mollah, J Le Huray | | |
| Automated characterization of the lipid nanoparticle ionizable lipid, DODAP, and its degradants using Molecule Profiler software Z Yang, S Mollah, H Kaluarachchi, W Jin, M Al-Dulaymi | | |
| Zirconium-89 Labeled Gene Delivery Nanoparticles as Theranostic Agents for Melanoma I Hajdu, D Michel, M Al-Dulaymi, W Mohammed-Saeid, K Wasan, ... | | |
Ildiko BadeaUniversity of Saskatchewan在 usask.ca 的电子邮件经过验证
